MedTrace Logo

Postoperative Analgesic Effects of Using Dexmedetomidine for Ultrasound Guided Thoracic Paravertebral Block

NCT02544893 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 93

Last updated 2016-08-03

No results posted yet for this study

Summary

we aimed postoperative analgesic effects of using bupivacaine alone or added dexmedetomidine for ultrasound guided thoracic paravertebral block in thoracotomy

Conditions

Interventions

DRUG

bupivacaine

21 ml 0.5 %bupivacaine is applied paravertebral space

DRUG

dexmedetomidin

1 ml dexmedetomidin + 20 ml 0.5 % bupivacaine are applied paravertebral space

DRUG

serum physiologic

21 ml serum physiologic is applied paravertebral space

Sponsors & Collaborators

  • TC Erciyes University

    lead OTHER

Principal Investigators

  • esra n ünalan, resident · TC Erciyes University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2016-03-31
Completion
2016-03-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02544893 on ClinicalTrials.gov